Kim Kelderman is General Manager of GeneOhm Sciences Canada, Inc. Prior to joining GeneOhm Sciences Canada, he was Chief Operating Officer and a Director of Oculus Innovative Sciences, Inc. Mr. Kelderman was President and General Manager of Jomed, Inc. (formerly EndoSonics Corp.). Previously, he held senior management positions at Intravascular Research Ltd., Jomed GmbH, EndoSonics Europe, and Medtronic Vascular, Inc. Mr. Kelderman received a degree in Mechanical Engineering from the Heerlen Polytechnic and Eindhoven University.
|05/01/2021||856||Derivative/Non-derivative trans. at $427.49 per share.||365,932|
|05/01/2021||1,667||Derivative/Non-derivative trans. at $0 per share.||0|
|02/05/2021||823||Disposition at $388.45 per share.||319,695|
|05/01/2020||821||Derivative/Non-derivative trans. at $227.54 per share.||186,811|
|05/01/2020||1,666||Derivative/Non-derivative trans. at $0 per share.||0|
|05/01/2019||844||Derivative/Non-derivative trans. at $202.13 per share.||170,598|
|05/01/2019||1,667||Derivative/Non-derivative trans. at $202.13 per share.||336,950|